Leitch H - Search Results

1

Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities.

Vercauteren SM, Sung S, Starczynowski DT, Lam WL, Bruyere H, Horsman DE, Tsang P, Leitch H, Karsan A. Vercauteren SM, et al. Among authors: leitch h. Am J Clin Pathol. 2010 Jul;134(1):119-26. doi: 10.1309/AJCPH27ZIZEJLORF. Am J Clin Pathol. 2010. PMID: 20551276

2

Rapid determination of Epstein-Barr virus latent or lytic infection in single human cells using in situ hybridization.

Leenman EE, Panzer-Grümayer RE, Fischer S, Leitch HA, Horsman DE, Lion T, Gadner H, Ambros PF, Lestou VS. Leenman EE, et al. Among authors: leitch ha. Mod Pathol. 2004 Dec;17(12):1564-72. doi: 10.1038/modpathol.3800228. Mod Pathol. 2004. PMID: 15545957 Free article.

3

Improved survival in HIV-associated diffuse large B-cell lymphoma with the addition of rituximab to chemotherapy in patients receiving highly active antiretroviral therapy.

Ezzat H, Filipenko D, Vickars L, Galbraith P, Li C, Murphy K, Montaner JS, Harris M, Hogg RS, Vercauteren S, Leger CS, Zypchen L, Leitch HA. Ezzat H, et al. Among authors: leitch ha. HIV Clin Trials. 2007 May-Jun;8(3):132-44. doi: 10.1310/hct0803-132. HIV Clin Trials. 2007. PMID: 17621460

4

Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada.

Lee LJ, Toze CL, Huang SJT, Gillan TL, Connors JM, Sehn LH, Bruyere H, Leitch H, Ramadan KM, Gerrie AS. Lee LJ, et al. Among authors: leitch h. Leuk Lymphoma. 2018 Jun;59(6):1356-1363. doi: 10.1080/10428194.2017.1387904. Epub 2017 Oct 16. Leuk Lymphoma. 2018. PMID: 29032719

5

Management of patients with lower-risk myelodysplastic syndromes.

Brunner AM, Leitch HA, van de Loosdrecht AA, Bonadies N. Brunner AM, et al. Blood Cancer J. 2022 Dec 14;12(12):166. doi: 10.1038/s41408-022-00765-8. Blood Cancer J. 2022. PMID: 36517487 Free PMC article. Review.

6

Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy.

Leitch HA. Leitch HA. Leuk Res. 2007 Dec;31 Suppl 3:S7-9. doi: 10.1016/S0145-2126(07)70460-5. Leuk Res. 2007. PMID: 18037416 Review.

7

Acute leukemia in patients sixty years of age and older: a twenty year single institution review.

Leger CS, Leitch HA, Galbraith PF, Li CH, Vickars LM. Leger CS, et al. Among authors: leitch ha. Am J Clin Oncol. 2009 Apr;32(2):137-41. doi: 10.1097/COC.0b013e31818a6c93. Am J Clin Oncol. 2009. PMID: 19307947 Clinical Trial.

8

Controversies surrounding iron chelation therapy for MDS.

Leitch HA. Leitch HA. Blood Rev. 2011 Jan;25(1):17-31. doi: 10.1016/j.blre.2010.09.003. Epub 2010 Oct 27. Blood Rev. 2011. PMID: 21030120 Review.

9

Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Leitch HA. Leitch HA. Drugs. 2011 Jan 22;71(2):155-77. doi: 10.2165/11585280-000000000-00000. Drugs. 2011. PMID: 21275444 Review.

10

The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guideline.

Leitch HA, Buckstein R, Shamy A, Storring JM. Leitch HA, et al. Crit Rev Oncol Hematol. 2013 Feb;85(2):162-92. doi: 10.1016/j.critrevonc.2012.07.003. Epub 2012 Aug 15. Crit Rev Oncol Hematol. 2013. PMID: 22901762 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters